Insiders Intellia Therapeutics, Inc.

Equities

NTLA

US45826J1051

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-12 pm EDT			5-day change	1st Jan Change
25.85 ^USD	+8.84%		+11.18%	-15.22%

Jun. 03	Intellia Therapeutics Shares Rise as NTLA-2002 Phase 1 Study Observes 98% Mean Reduction in Monthly Attack Rate	MT
Jun. 03	Transcript : Intellia Therapeutics, Inc. - Special Call

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Intellia Therapeutics, Inc. Appoints Michael P. Dube as Principal Accounting Officer	Apr. 15	CI
Intellia Therapeutics Insider Sold Shares Worth $566,310, According to a Recent SEC Filing	Jan. 05	MT
Intellia Therapeutics, Inc. Announces Resignation of John F. Crowley from the Board of Directors of Company and Its Committees	Dec. 06	CI
Intellia Therapeutics, Inc. Appoints Eliana Clark, Phd, Executive Vice President and Chief Technical Officer	23-07-19	CI
Insider Sell: Intellia Therapeutics	23-06-22	MT
Intellia Therapeutics, Inc. Announces Resignation of Jean-François Formela as Board Member	23-06-05	CI
Intellia Therapeutics, Inc. Appoints Bill Chase to Its Board of Directors and Member of the Audit Committee	23-04-17	CI
Intellia Therapeutics, Inc. Announces Resignation of Caroline Dorsa from the Board of Directors and Committees, Effective June 15, 2023	23-03-24	CI
Insider Sell: Intellia Therapeutics	23-01-06	MT
Intellia Therapeutics, Inc. Names Muna Bhanji to Its Board of Directors	22-05-02	CI
Intellia Therapeutics, Inc. Appoints Derek Hicks as Chief Business Officer	21-12-20	CI
Insider Sell: Intellia Therapeutics	21-10-13	MT
Insider Sell: Intellia Therapeutics	21-10-08	MT
Insider Sell: Intellia Therapeutics	21-09-09	MT
Insider Trends: 90-Day Insider Selling Trend Prolonged at Intellia Therapeutics	21-06-29	MT
Intellia Therapeutics, Inc. Announces Management Changes	21-06-24	CI
Andrew Schiermeier, Ph.D. to Resign as Executive Vice President and Chief Operating Officer of Intellia Therapeutics, Inc	21-06-22	CI
Blackstone Life Sciences, Cellex Cell Professionals, and Intellia Therapeutics, Inc. Announce Management Appointments for the New Company	21-06-22	CI
Insider Trends: Insider Prolongs 90-Day Selling Trend at Intellia Therapeutics	21-06-15	MT
Insider Trends: Insider 90-Day Selling Trend Extended at Intellia Therapeutics	21-04-30	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Intellia Therapeutics, Inc.

Equities

NTLA

US45826J1051

Insiders

Filters